156 related articles for article (PubMed ID: 2262370)
21. Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas.
Schwartz C; Romagna A; Thon N; Niyazi M; Watson J; Belka C; Tonn JC; Kreth FW; Nachbichler SB
Acta Neurochir (Wien); 2015 Oct; 157(10):1757-64; discussion 1764. PubMed ID: 26298594
[TBL] [Abstract][Full Text] [Related]
22. [Volumetric changes following 125I interstitial brachytherapy of gliomas].
Julow J; Viola A; Major T; Mangel L; Bajzik G; Repa I; Sági S; Valálik I; Emri M; Trón L; Németh G
Ideggyogy Sz; 2005 Mar; 58(3-4):120-32. PubMed ID: 15887415
[TBL] [Abstract][Full Text] [Related]
23. The relationship between the technical accuracy of stereotactic interstitial implantation for high grade gliomas and the pattern of tumor recurrence.
Schupak K; Malkin M; Anderson L; Arbit E; Lindsley K; Leibel S
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1167-76. PubMed ID: 7607939
[TBL] [Abstract][Full Text] [Related]
24. Permanent iodine-125 interstitial radiation therapy in the treatment of non-glioblastoma multiforme high-grade gliomas.
Zamorano L; Li Q; Tekyi-Mensah S; Gaspar L; Fontanesi J; Levin K
Stereotact Funct Neurosurg; 2003; 81(1-4):10-7. PubMed ID: 14742958
[TBL] [Abstract][Full Text] [Related]
25. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
26. High activity iodine-125 interstitial implant for gliomas.
Scharfen CO; Sneed PK; Wara WM; Larson DA; Phillips TL; Prados MD; Weaver KA; Malec M; Acord P; Lamborn KR
Int J Radiat Oncol Biol Phys; 1992; 24(4):583-91. PubMed ID: 1429079
[TBL] [Abstract][Full Text] [Related]
27. Brachytherapy of recurrent malignant brain tumors with removable high-activity iodine-125 sources.
Gutin PH; Phillips TL; Wara WM; Leibel SA; Hosobuchi Y; Levin VA; Weaver KA; Lamb S
J Neurosurg; 1984 Jan; 60(1):61-8. PubMed ID: 6358430
[TBL] [Abstract][Full Text] [Related]
28. Brachytherapy of Intracranial Gliomas.
Nachbichler SB; Kreth FW
Prog Neurol Surg; 2018; 31():72-86. PubMed ID: 29393178
[TBL] [Abstract][Full Text] [Related]
29. Brachytherapy for recurrent malignant astrocytoma.
Bernstein M; Laperriere N; Glen J; Leung P; Thomason C; Landon AE
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1213-7. PubMed ID: 7961031
[TBL] [Abstract][Full Text] [Related]
30. Radiosurgery as part of the initial management of patients with malignant gliomas.
Loeffler JS; Alexander E; Shea WM; Wen PY; Fine HA; Kooy HM; Black PM
J Clin Oncol; 1992 Sep; 10(9):1379-85. PubMed ID: 1325539
[TBL] [Abstract][Full Text] [Related]
31. Preliminary results of interstitial 192Ir brachytherapy for malignant gliomas.
Matsumoto K; Nakagawa M; Higashi H; Maeshiro T; Tsuno K; Mishima N; Furuta T; Ohmoto T; Taguchi K; Nakagawa T
Neurol Med Chir (Tokyo); 1992 Sep; 32(10):739-46. PubMed ID: 1280775
[TBL] [Abstract][Full Text] [Related]
32. Computer planning of stereotactic iodine-125 seed brachytherapy for recurrent malignant gliomas.
Hughes SW; Sofat A; Kitchen ND; Brown A; Beaney RP; Timothy AR; Saunders JE; Thomas DG
Br J Radiol; 1995 Feb; 68(806):175-81. PubMed ID: 7537597
[TBL] [Abstract][Full Text] [Related]
33. Malignant glioma: patterns of failure following individually tailored limited volume irradiation.
Hess CF; Schaaf JC; Kortmann RD; Schabet M; Bamberg M
Radiother Oncol; 1994 Feb; 30(2):146-9. PubMed ID: 8184112
[TBL] [Abstract][Full Text] [Related]
34. Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources.
Gutin PH; Leibel SA; Wara WM; Choucair A; Levin VA; Philips TL; Silver P; Da Silva V; Edwards MS; Davis RL
J Neurosurg; 1987 Dec; 67(6):864-73. PubMed ID: 3316532
[TBL] [Abstract][Full Text] [Related]
35. Patterns of relapse in patients with high grade glioma receiving combined treatments including stereotactic re-irradiation for a first relapse.
Antoni D; Jastaniah Z; Haoming QC; Gaultier C; Ahle G; Couchot J; Atlani D; Schott R; Clavier JB; Srour R; Chaussemy D; Noël G
Cancer Radiother; 2016 Jun; 20(4):282-91. PubMed ID: 27318555
[TBL] [Abstract][Full Text] [Related]
36. On a method of dosimetry planning and implantation of 125I for interstitial irradiation of malignant gliomas.
Eddy MS; Selker RG; Anderson LL
J Neurooncol; 1986; 4(2):131-9. PubMed ID: 3783208
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic brachytherapy for malignant glioma using a relocatable frame.
Sofat A; Hughes S; Briggs J; Beaney RP; Thomas DG
Br J Neurosurg; 1992; 6(6):543-8. PubMed ID: 1472320
[TBL] [Abstract][Full Text] [Related]
38. [Afterloading technic for the interstitial irradiation of recurrent gliomas].
Nomura K; Shibui S; Miki Y; Kakehi M; Kitagawa T
Neurol Med Chir (Tokyo); 1983 Sep; 23(9):735-40. PubMed ID: 6196669
[No Abstract] [Full Text] [Related]
39. Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: the UCSF experience.
Prados MD; Gutin PH; Phillips TL; Wara WM; Sneed PK; Larson DA; Lamb SA; Ham B; Malec MK; Wilson CB
Int J Radiat Oncol Biol Phys; 1992; 24(4):593-7. PubMed ID: 1429080
[TBL] [Abstract][Full Text] [Related]
40. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
